Year None202320222021202020192018201720162015201420132012 01.05.2021 Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 12.17.2020 Iveric Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference 12.04.2020 Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 11.02.2020 Iveric Bio Reports Third Quarter 2020 Operational Highlights and Financial Results 10.29.2020 Iveric Bio to Participate in Upcoming Virtual Investor / Industry Conferences 10.26.2020 Iveric Bio to Report Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 2, 2020 10.02.2020 Iveric Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 09.03.2020 Iveric Bio to Participate in Upcoming September Investor / Industry Conferences 09.02.2020 Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 09.01.2020 Iveric Bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of Ophthalmology Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page next › Last page last »